Skip survey header

K851 Evaluation - 7/29

Saving the Hearts of Women Through Prevention
Friday, July 29, 2022 | 1:45PM  ̶  4:15PM
Your evaluation of this activity is extremely important, as it allows us to plan for future educational programs. Please take a moment to answer the following questions.
1. Please indicate your degree: *This question is required.
2. Please indicate your primary specialty: *This question is required.
3. Please indicate your primary professional/practice setting: *This question is required.
4. How many years have you been managing patients with cardiovascular (CV) risk? *This question is required.
5. Approximately how many patients with CV risk do you see per week? *This question is required.
6. How likely are you to recommend this activity to a colleague (1 = Not at all likely; 10 = Extremely likely)? *This question is required.
12345678910
7. Do you believe this program: *This question is required.
Space Cell YesNoN/A
Achieved its identified educational goals and learning objectives? *This question is required
Covered content that is relevant and will be useful to your practice? *This question is required
Will increase your competence in managing these patients? *This question is required
Used teaching methods and educational formats that were effective for learning? *This question is required
Provided you with resources to use in your practice and/or with your patients? *This question is required
Addressed and provided strategies for overcoming barriers to optimal patient care? *This question is required
Was presented objectively and was free of commercial bias*? *This question is required
8. Future activities concerning this subject matter are necessary. *This question is required.
9. Approximately what percentage of the activity’s content was NEW to you? *This question is required.
0%25%50%75%100%
10. I plan to make the following changes to my practice. *This question is required.
Space Cell YesNoI Already Do
This in My Practice
N/A
Recognize gender-specific factors that have an impact on CV risk in women.
Incorporate clinical guidelines and modalities that improve the screening of women for CV risk.
Apply the latest clinical data into practice regarding the impact of weight loss on CV risk in women.
Apply recent clinical data into practice regarding newer anti-diabetes medications and their impact on CV risk.
Apply recent data into practice regarding the impact of non-statin therapies on the reduction of LDL-C or triglycerides in patients with atherosclerotic cardiovascular disease (ASCVD) with or without risk enhancers.
13. Barriers to Practice
The following are barriers I face most often in my current practice that impact my ability to provide optimal care: *This question is required.
Space Cell YesNoN/A
Lack of time to stay current on the latest evidence-based care *This question is required
Implementing value-based metrics/quality measures *This question is required
Insurance/financial restrictions *This question is required
Lack of patient adherence/compliance to therapy *This question is required
14. How confident are you in your ability to apply recent data into practice regarding the impact of therapies on the reduction of LDL-C or triglycerides in patients with ASCVD with or without risk enhancers? *This question is required.